RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 VT-1161 Emerges as Potential Treatment for Acute Vulvovaginal Candidiasis
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 48
SP 19
OP 19
DO 10.1177/1559897715591486
UL http://mdc.sagepub.com/content/15/48/19.2.abstract
AB The novel agent VT-1161 is safe and as effective as fluconazole for treating acute vulvovaginal candidiasis infections. Furthermore, it is more effective than fluconazole for preventing recurrent vulvovaginal candidiasis infections, particularly at its mid- and high doses, according to results from a phase 2 dose-ranging study. VT-1161 is now being evaluated in patients with recurrent vulvovaginal candidiasis in the REVIVE trial.